The unique ability to specifically bind to the nucleic acid sequence makes oligonucleotide (ON) a promising agent in the medical field. Moreover, the capability of ONs to exert the aforementioned biological mechanisms via sequence-specific molecular recognition makes them highly attractive candidates for drug development.
Here are Top 10 companies in Oligonucleotide synthesis market
Founded in 1969 and is headquartered at Washington, the U.S.; Danaher Corporation designs, manufactures, and markets professional, medical, industrial and commercial products and services. The company operates through four business segments namely Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions. The company operates into Oligonucleotide synthesis market through its subsidiary Integrated DNA Technologies, Inc. (IDT). From March 2018, IDT operates as a subsidiary of Danaher Corporation. The IDT develops, manufactures, and supplies various types of custom oligonucleotides for research and diagnostics life sciences industry in the areas of academic research, biotechnology, agriculture, medical diagnostics, and pharmaceutical development.
The company has a strong geographic presence across North America, Europe, Asia-Australia, Latin America, and Middle East & Africa.
Founded in 1668 and is headquartered at Darmstadt, Germany; Merck KGaA is engaged in the manufacturing of products and services for genomics, proteomics, and cellular analysis. The company operates through following business segments: healthcare, life science, and performance materials. The company provides products for analytical and sample preparations, biopharmaceutical manufacturing, industrial microbiology, life science research, and IVD materials & reagents. Merck provides wide range of oligonucleotide products through its subsidiary, Sigma-Aldrich.
With its subsidiaries and network of distribution, Merck has its presence in the North America, Europe, Asia Pacific, Latin America, and Middle East and Africa.
Eurofins Scientific SE
Founded in 1987 and is headquartered in Luxembourg, Europe. Eurofins Scientific SE offers a portfolio of over 150,000 analytical methods and more than 150 million assays performed each year to establish the safety, identity, composition, authenticity, origin, traceability, and purity of biological substances and products, as well as carry out human diagnostic services. Eurofins Scientific provides wide range of oligonucleotide products through its subsidiary, Eurofins Genomics. Eurofins Genomics is an international provider of genomic services established around the core business lines of next generation sequencing, custom DNA sequencing, DNA and RNA oligonucleotides, siRNA and gene synthesis and molecular biology services.
The company has its geographic presence across 44 countries in Europe, North and South America, and Asia-Pacific.
Thermo Fisher Scientific Inc.
Founded in 2006 and is headquartered at Waltham, Massachusetts, the U.S.; Thermo Fisher Scientific Inc. is engaged in providing analytical instruments, equipment, reagents and consumables, software and services for research, manufacturing, analysis, discovery, and diagnostics services under the brands Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, and Unity Lab Services worldwide. The company operates through four business segments, namely, Analytical Instruments, Life Sciences Solutions, Laboratory Products and Services, and Specialty Services. The company provides oligonucleotide products through Invitrogen, under life Sciences solutions business segment.
With its subsidiaries and strong network of distribution, the company has its presence across North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.
Agilent Technologies, Inc.
Founded in 1999 and is headquartered at Santa Clara, California, the U.S.; Agilent Technologies, Inc. is engaged in life sciences, diagnostics, and applied chemical markets to provide the focused solutions by offering instruments, software, and services. The company operates through the following business segments: Life Sciences and Applied Markets Group, Agilent CrossLab Group, and Diagnostics and Genomics. The company provides oligonucleotides products under Diagnostics and Genomics business segment.
With its subsidiaries and strong distribution network, the company has its presence across North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.
Founded in 1994 and is headquartered at Chicago, Illinois, the U.S.; GE Healthcare is engaged in manufacturing medical equipment. It is a subsidiary of General Electric (GE) Company. The company’s businesses are majorly segmented into two sub-categories namely healthcare systems and life sciences. The company offers the broad range of oligonucleotide synthesis equipment, reagents, and other tools through its life sciences business segment.
With its subsidiaries and strong network of distribution, the company serves more than 140 countries globally with its presence in various regions such as North America, Europe, Asia- Pacific, Latin America, and Middle East & Africa. The major subsidiaries of GE Healthcare are Amersham (U.K.), Biacore (Slovakia), API Healthcare (U.S.), and more.
Meticulous Research in its latest publication on global Oligonucleotide synthesis market has predicted the growth of 10.5% during the forecast year 2019-2025.
Kaneka Eurogentec S.A.
Founded in 1985 and is headquartered in Liege Science Park, Belgium; Kaneka Eurogentec S.A., a subsidiary of Kaneka Corporation, supplies innovative reagents, kits, specialty products, and custom services. The company provides its products through three business units including life science research, diagnostics services, and GMP manufacturing. The life sciences business unit provides a wide range of reagents, kits and consumables for Life Science applications such as custom oligonucleotides, high performance PCR/qPCR kits & reagents, catalogue dyes, peptides & antibodies. Eurogentec is also specialist in the design and synthesis of custom peptides and production of custom antibodies.
With its subsidiaries, the company has its presence across France, Germany, U.K., the Netherlands and Switzerland and production facilities in Liège (BE), Camberly (U.K.) and Fremont (U.S.).
Founded in 2000 and is headquartered at Osaka, Japan; GeneDesign, Inc. provides specific nucleic acid materials such as artificial nucleic acid BNA (Bridged Nucleic Acid), ribbon type decoy nucleic acid, ICON probe, Chum-RNA, etc. and develop new technologies by application of gene related technologies such as drug development, and diagnostics technology development.
The company operates as a subsidiary of Ajinomoto Co., Inc. The Ajinomoto Co., Inc. provide its products through the major segments namely Japan food products, international food products, life support, healthcare, and other. The company operates as an oligonucleotide manufacturer with broad capacity for DNA/RNA/LNA oligonucleotide synthesis from micro to gram scale.
LGC Biosearch Technologies
Founded in 1993 and is headquartered at Petaluma, California, the U.S.; LGC Biosearch Technologies operates as subsidiary of LGC Group. The company designs, develop, and manufacture custom oligonucleotide-based tools and associated reagents for the molecular diagnostics industry. LGC Bioresearch provides products to pharmaceutical; in vitro diagnostics; biotechnology; agricultural biotechnology; environmental and food testing; public health; and biodefense sectors. LGC further strengthened their nucleic acid chemistry offering through the acquisition of BioAutomation Corporation (BioAutomation), manufacturer of the renowned MerMade oligo synthesis instruments.
With its subsidiaries and strong network of distribution, the company has its presence in various regions such as North America, Europe, Asia- Pacific, Latin America, and Middle East & Africa.
Founded in 1984 and headquartered at Lewisville, Texas, the U.S.; Bio-synthesis Inc. is a manufacturer of high-quality oligonucleotide, peptides, and other molecular biology products. The company provides the custom peptide synthesis and oligonucleotide synthesis for the research, diagnostics, and therapeutic industries. As an established company in oligonucleotide synthesis, Bio-Synthesis has been adopted the development of new oligonucleotide-based techniques that can produce compounds with superior binding affinity and chemical/biological stability. Moreover, company is also providing a third generation of nucleic acid analog, called as Bridged Nucleic Acid (BNA).
With its subsidiaries and strong network of distribution, the company has its presence in various regions such as North America, Europe, Asia- Pacific, Latin America, and Middle East.
Popular mentions: TriLink BioTechnologies, LLC, and ATDBio Ltd.
Authoritative Research on the Oligonucleotide Synthesis Market – Global Opportunity Analysis and Industry Forecast (2019-2025)
Need more information? Meticulous Research®’s new report covers each of these companies in much more detail, providing analysis on the following:
- Recent financial performance
- Key products
- Significant company strategies
- Partnerships and acquisitions
- Impact of COVID-19 on the Oligonucleotide Synthesis Market
Comprehensive report provides global market size estimates, market share analysis, revenue numbers, and coverage of key issues and trends.
Please download report pages and learn more: https://www.meticulousresearch.com/download-sample-report/cp_id=4953